Investing

Applied Therapeutics : APLT

APLT

Stock Data

$0.10

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Applied Therapeutics Inc is a New York-based biopharmaceutical firm focused on developing innovative treatments for rare diseases affecting the central nervous system and complications arising from diabetes. Its flagship product, AT-007, is making strides in clinical trials for galactosemia, a rare metabolic disorder, with additional studies targeting other conditions like sorbitol dehydrogenase deficiency. The company is also advancing AT-001 for diabetic cardiomyopathy and AT-003 for diabetic retinopathy, showcasing its commitment to addressing unmet medical needs in both rare diseases and diabetes-related complications.

All Applied Therapeutics Articles

2 Articles

Chris Lange | Aug 27, 2021 at 9:08 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Advance Auto Parts, AutoZone, Chesapeake, Dollar Tree, HP, Marvell and More

Friday’s top analyst upgrades and downgrades included Advance Auto Parts, AutoZone, Chesapeake Energy, Deckers Outdoor, Dollar Tree, HP and Marvell…

Chris Lange | Oct 8, 2020 at 11:51 AM EDT

Could Applied Therapeutics Stock Rise 300%?

Applied Therapeutics shares pushed higher on Thursday after a new analyst report came out supposing massive upside for this biotech.